Skytrofa (lonapegsomatropin-tcgd) is a long-acting growth hormone deficiency treatment. It can cause a number of side effects ranging from mild and temporary to serious enough to require medical ...

(RTTNews) - Ascendis Pharma A/S (ASND), on Friday, announced that its supplemental Biologics License Application seeking approval of Skytrofa in the proposed treatment of adults with growth hormone ...

Ascendis Pharma's supplemental application for SKYTROFA in adult GHD has been accepted by the FDA, aiming for broader patient access. Acceptance of the sBLA does not guarantee approval; the company ...

The price you pay for Skytrofa may depend on factors such as your dosage, whether you have health insurance, and the pharmacy you use. Financial assistance may be available to help you with the cost ...

Shares of Ascendis Pharma (ASND) did not move much after the company reported positive phase 2 results from the COACH trial that investigated the combination of TransCon CNP and Skytrofa in ...